osteoarthritis
Scope
Date
~
-
Bio & PharmaLG Chem launches Synovian in China
South Korea's LG Chem Ltd. announced on Wednesday that it launched its homegrown new drug for osteoarthritis Synovian (marketed in China as Hyruan O...
Jul 03, 2024 (Gmt+09:00)
-
Bio & PharmaCrystalGenomics to supply anti-osteoarthritis drug to Russia for $2 mn
South Korea's first-generation biopharma venture company CrystalGenomics Inc. on Wednesday said it received a $2 million (2.6 billion won) order fro...
Jun 08, 2023 (Gmt+09:00)
-
Bio & PharmaMedipost completes first dose of Cartistem in phase 3 clinical trials in Japan
South Korea's stem cell research company Medipost Co. said on Monday that it has completed the administration of Cartistem, a stem cell treatment fo...
Jan 17, 2023 (Gmt+09:00)
-
Bio & PharmaKolon Life inks technology transfer deal with Juniper Biologics
South Korea’s pharmaceutical company Kolon Life Science Inc. signed a technology export deal worth up to 723.4 billion won ($589.1 million) wi...
Apr 13, 2022 (Gmt+09:00)
Latest News
- 1 Lotte Chemical, HD Hyundai seek big deal via merger of naphtha cracking facilities
- 2 South Korea accelerates stablecoin framework amid global race
- 3 Lee vows policy overhaul to spur dividend payouts
- 4 IFEZ to apply for designation of southern Gangwha as free economic zone
- 5 Jollibee to buy chicken chain Norang Tongdak amid global K-food frenzy
